5 recruiting. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 5 |
| Phase 3 | 3 | Recruiting 3 |
Follow Heart Failure With Reduced Ejection Fraction: new trials by email Literature Review of Heart Failure With Reduced Ejection Fraction trials Research Report on Heart Failure With Reduced Ejection Fraction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension Midodrine Oral Tablet - Heart Failure With Reduced Ejection Fraction, Hypotension | Phase 2 / Phase 3 | Recruiting | Ottawa Heart Institute Research Corporation | 56 | 2026-08-07 | 2026-09-08 |
| Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients Lumacaftor 200 MG, Placebo - Heart Failure With Reduced Ejection Fraction | Phase 2 | Recruiting | Qanatpharma AG | 60 | 2026-07-01 | 2026-07-17 |
| Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy GDMT - Heart Failure With Reduced Ejection Fraction, Heart Rhythm Disorder | Phase 2 / Phase 3 | Recruiting | Herlev and Gentofte Hospital | 348 | 2025-01-09 | 2026-02-23 |
| Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure Vsling - Heart Failure With Reduced Ejection Fraction | Phase 2 | Recruiting | Cardiac Success | 20 | 2024-11-15 | 2026-10-28 |
| Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure Semaglutide Injectable Product, Calorie-restricted diet - Heart Failure With Reduced Ejection Fraction, Obesity | Phase 2 / Phase 3 | Recruiting | Jens D Hove, MD,PHD | 100 | 2024-04-30 | 2026-06-23 |
Heart Failure (2) · Cognitive Dysfunction (1) · Hypotension (1) · Obesity (1) · Ventricular Dysfunction, Left (1) · Weight Loss (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Body Weight (1) · Body Weight Changes (1) · Cognition Disorders (1) · Mental Disorders (1) · Neurocognitive Disorders (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Vascular Diseases (1) · Ventricular Dysfunction (1)
Caloric Restriction (1) · Midodrine (1) · lumacaftor (1)
Cardiac Success (1) · Herlev and Gentofte Hospital (1) · Jens D Hove, MD,PHD (1) · Ottawa Heart Institute Research Corporation (1) · Qanatpharma AG (1)
Canada (2) · Denmark (2) · Israel (1)
Emil Wolsk, MD (1) · Ian Paterson, MD (1) · Jens D Hove (1) · Kim Connelly (1)
2023 (1)